Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 9, 2012, Pages 1200-1210

  Kar, Subhabrata ^a   Patel, Mitulkumar A ^a   Tripathy, Rajan K ^a   Bajaj, Priyanka ^a   Suvarnakar, Unnati V ^a   Pande, Abhay H ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Apolipoprotein A I; ATR FTIR; Fluorescence spectroscopy; Ox PL; Paraoxonase 1; rHDL

Indexed keywords

APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ARTICLE; ENZYME ACTIVATION; LIPID OXIDATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE;

APOLIPOPROTEIN A-I; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; HUMANS; LIPOPROTEINS, HDL; OXIDATION-REDUCTION; PHOSPHOLIPIDS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84862323223     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.05.002     Document Type: Article

References (65)

1. D.J. Rader Molecular regulation of HDL metabolism and function: implications for novel therapies J. Clin. Invest. 116 2006 3090 3100
2. J.E. Feig, R. Shamir, and E.A. Fisher Atheroprotective effects of HDL: beyond reverse cholesterol transport Curr. Drug Targets 9 2008 196 203
3. M. Navab, G.M. Ananthramaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, G.C. Fonarow, K. Vahabzadeh, S. Hama, G. Hough, N. Kamranpour, J.A. Berliner, A.J. Lusis, and A.M. Fogelman The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL J. Lipid Res. 45 2004 993 1007
4. B.J. Ansell, G.C. Fonarow, and A.M. Fogelman The paradox of dysfunctional high-density lipoprotein Curr. Opin. Lipidol. 18 2007 427 434
5. B. Shao, S. Pennathur, I. Pagani, M.N. Oda, J.L. Witztum, J.F. Oram, and J.W. Heinecke Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway J. Biol. Chem. 285 2010 18473 18484
6. A. Undurti, Y. Huang, J.A. Lupica, J.D. Smith, J.A. DiDonato, and S.L. Hazen Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle J. Biol. Chem. 284 2009 30825 30835
7. M. Navab, S.Y. Hama, G.P. Hough, G. Subbanagounder, S.T. Reddy, and A.M. Fogelman A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids J. Lipid Res. 42 2001 1308 1317
8. S.W. Davidson, and T.B. Thompson The structure of apolipoprotein A-I in high density lipoproteins J. Biol. Chem. 282 2007 22249 22253
9. Z. Wu, V. Gogonea, X. Lee, M.A. Wagner, X.-M. Li, Y. Huang, U. Arundhati, R.P. May, M. Haertlein, M. Moulin, I. Gutsche, G. Zaccai, J. DiDonato, and S.L. Hazen Double superhelix model of high density lipoprotein J. Biol. Chem. 284 2009 36605 36619
10. M.K. Jones, L. Zhang, A. Catte, L. Li, M.N. Oda, G. Ren, and J.P. Segrest Assessment of the validity of the double superhelix model for reconstituted high density lipoproteins: a combined computational-experimental approach J. Biol. Chem. 285 2010 41161 41171
11. R. Huang, R.A. Silva, W.G. Jerome, A. Kontush, M.J. Chapman, L.K. Curtiss, T.J. Hodges, and S.W. Davidson Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma Nat. Struct. Mol. Biol. 4 2011 416 422
12. V. Gogonea, Z. Wu, X. Lee, V. Pipich, X.-M. Li, A.I. Ioffe, J.A. DiDonato, and S.L. Hazen Congruency between biophysical data from multiple platforms and molecular dynamics simulation of the double-super helix model of nascent high-density lipoprotein Biochemistry 49 2010 7323 7343
13. J.O. Lagerstedt, G. Cavigiolio, M.S. Budamagunta, I. Pagani, C.J. Voss, and M.N. Oda Structure of apolipoprotein A-I's N-terminus on nascent high density lipoproteins J. Biol. Chem. 286 2010 2966 2975
14. B. Shao, G. Cavigiolio, N. Brot, M.N. Oda, and J.W. Heinecke Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I Proc. Natl. Acad. Sci. U. S. A. 105 2008 12224 12229
15. V.N. Bochkov, O.V. Oskolkova, K.G. Birukov, A.L. Levonen, C.J. Binder, and J. Stockl Generation and biological activities of oxidized phospholipids Antioxid. Redox Signal. 12 2010 1009 1059
16. A. Catalá Lipid peroxidation of membrane phospholipids generates hydroxyalkenals and oxidized phospholipids active in physiological and/or pathological conditions Chem. Phys. Lipids 157 2009 1 11
17. G.O. Fruhwirth, A. Loidl, and A. Hermetter Oxidized phospholipids: from molecular properties to disease Biochim. Biophys. Acta 1772 2007 718 736
18. M.Z. Ashraf, N.S. Kar, and E.A. Podrez Oxidized phospholipids: biomarker for cardiovascular diseases Int. J. Biochem. Cell Biol. 41 2009 1241 1244
19. C. Bergmark, A. Dewan, A. Orsoni, E. Merki, E.R. Miller, M.J. Shin, C.J. Binder, S. Horkko, R.M. Krauss, M.J. Chapman, J.L. Witztum, and S. Tsimikas A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma J. Lipid Res. 2008 2230 2239
20. R.G. Salomon, K. Kaur, E.A. Podrez, H.F. Hoff, A.V. Krushinsky, and L.M. Sayre HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques Chem. Res. Toxicol. 13 2000 557 564
21. M.I. Mackness, B. Mackness, P.N. Durrington, P.W. Connelly, and R.A. Hegele Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins Curr. Opin. Lipidol. 7 1996 69 76
22. H. Tavori, J. Vaya, and M. Aviram Paraoxonase 1 attenuates human plaque atherogenicity: relevance to the enzyme lactonase activity Adv. Exp. Med. Biol. 660 2010 99 111
23. M. Rosenblat, L. Gaidukov, O. Khersonsky, J. Vaya, R. Oren, D.S. Tawfik, and M. Aviram The catalytic histidine dyad of high density lipoprotein- associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux J. Biol. Chem. 281 2006 7657 7665
24. B. Mackness, and M. Mackness Anti-inflammatory properties of paraoxonase-1 in atherosclerosis Adv. Exp. Med. Biol. 660 2010 143 151
25. D. Rochu, E. Chabriere, and P. Masson Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning Toxicology 233 2007 47 59
26. C. Morgantini, A. Natali, B. Boldrini, S. Imaizumi, M. Navab, A.M. Fogelman, E. Ferrannini, and S.T. Reddy Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes Diabetes 60 2010 2617 2623
27. A.D. Watson, N. Leitinger, M. Navab, K.F. Faull, S. Horkko, J.L. Witztum, W. Palinski, D. Schwenke, R.G. Salomon, W. Sha, G. Subbanagounder, A.M. Fogelman, and J.A. Berliner Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo J. Biol. Chem. 272 1997 13597 13607
28. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol. 52 1978 302 310
29. A. Jonas Reconstitution of high-density lipoproteins Methods Enzymol. 128 1986 553 582
30. S. Kar, V.A. Tillu, S.C. Meena, and A.H. Pande Closely related oxidized phospholipids differentially modulate the physicochemical properties of lipid particles Chem. Phys. Lipids 164 2010 54 61
31. M.A. Markwell, S.M. Haas, L.L. Bieber, and N.E. Tolbert A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples Anal. Biochem. 87 1978 206 210
32. C.H. Fiske, and Y. Subbarow The colorimetric determination of phosphorus J. Biol. Chem. 66 1925 375 400
33. C.C. Allain, L.S. Poon, C.S. Chan, W. Richmond, and P.C. Fu Enzymatic determination of total serum cholesterol Clin. Chem. 20 1974 470 475
34. A.H. Pande, S. Kar, and R.K. Tripathy Oxidatively modified fatty acyl chain determines physicochemical properties of aggregates of oxidized phospholipids Biochim. Biophys. Acta 1798 2010 442 452
35. A.H. Pande, and V.A. Tillu Membrane lipid composition differentially modulates the function of human plasma platelet activating factor- acetylhydrolase Biochim. Biophys. Acta 1811 2011 46 56
36. T. Parasassi, G. De Stasio, G. Ravagnan, R.M. Rusch, and E. Gratton Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence Biophys. J. 60 1991 179 189
37. J.R. Lakowicz Fluorescence Anisotropy, Principles of Fluorescence Spectroscopy 3rd ed. 2006 Kluwer Academic/Plenum Publishers New York 353 382
38. A.H. Pande, R.K. Tripathy, and S.A. Nankar Membrane surface charge modulates lipoprotein complex forming capability of peptides derived from the C-terminal domain of apolipoprotein E Biochim. Biophys. Acta 1788 2009 1366 1376
39. A. Chakrabartty, J.A. Schellman, and R.L. Baldwin Large differences in the helix propensities of alanine and glycine Nature 351 1991 586 588
40. E. Goormaghtigh, V. Raussens, and J.M. Ruysschaert Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes Biochim. Biophys. Acta 1422 1999 105 185
41. K.N. Nemec, A.H. Pande, S. Qin, R.J. Bieber Urbauer, S. Tan, D. Moe, and S.A. Tatulian Structural and functional effects of tryptophans inserted into the membrane-binding and substrate-binding sites of human group IIA phospholipase A2 Biochemistry 45 2006 12448 12460
42. S. Qin, A.H. Pande, K.N. Nemec, and S.A. Tatulian The N-terminal alpha-helix of pancreatic phospholipase A2 determines productive-mode orientation of the enzyme at the membrane surface J. Mol. Biol. 344 2004 71 89
43. S.A. Tatulian Attenuated total reflection Fourier transform infrared spectroscopy: a method of choice for studying membrane proteins and lipids Biochemistry 42 2003 11898 11907
44. V. Raussens, J. Drury, T.M. Forte, N. Choy, E. Goormaghtigh, J.M. Ruysschaert, and V. Narayanaswami Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain Biochem. J. 387 2005 747 754
45. S. Qin, A.H. Pande, K.N. Nemec, X. He, and S.A. Tatulian Evidence for the regulatory role of the N-terminal helix of secretory phospholipase A(2) from studies on native and chimeric proteins J. Biol. Chem. 280 2005 36773 36783
46. D. Marsh Infrared dichroism of isotope-edited alpha-helices and beta-sheets J. Mol. Biol. 338 2004 353 367
47. L. Gaidukov, and D.S. Tawfik High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with apoA-I Biochemistry 44 2005 11843 11854
48. C.C. De Vequi-Suplicy, C.R. Benatti, and M.T. Lamy Laurdan in fluid bilayers: position and structural sensitivity J. Fluoresc. 16 2006 431 439
49. M. Shinitzky, and Y. Barenholz Fluidity parameters of lipid regions determined by fluorescence polarization Biochim. Biophys. Acta 515 1978 367 394
50. M. Tanaka, P. Dhanasekaran, D. Nguyen, S. Ohta, S. Lund-Katz, M.C. Phillips, and H. Saito Contributions of the N- and C-terminal helical segments to the lipid-free structure and lipid interaction of apolipoprotein A-I Biochemistry 45 2006 10351 10358
51. D. Sviridov, A. Hoang, W. Huang, and J. Sasaki Structure-function studies of apoA-I variants: site-directed mutagenesis and natural mutations J. Lipid Res. 43 2002 1283 1292
52. M. Tanaka, M. Koyama, P. Dhanasekaran, D. Nguyen, M. Nickel, S. Lund-Katz, H. Saito, and M.C. Phillips Influence of tertiary structure domain properties on the functionality of apolipoprotein A-I Biochemistry 47 2008 2172 2180
53. L.M. Loura, R.F. de Almeida, A. Coutinho, and M. Prieto Interaction of peptides with binary phospholipid membranes: application of fluorescence methodologies Chem. Phys. Lipids 122 2003 77 96
54. P.S. Chetty, L. Mayne, S. Lund-Katz, D. Stranz, S.W. Englander, and M.C. Phillips Helical structure and stability in human apolipoprotein A-I by hydrogen exchange and mass spectrometry Proc. Natl. Acad. Sci. USA 106 2009 19005 19010
55. H.H. de Jongh, E. Goormaghtigh, and J.M. Ruysschaert Tertiary stability of native and methionine-80 modified cytochrome c detected by proton-deuterium exchange using on-line Fourier transform infrared spectroscopy Biochemistry 34 1995 172 179
56. U.P. Fringeli, and H.H. Gunthard Infrared membrane spectroscopy Mol. Biol. Biochem. Biophys. 31 1981 270 332
57. J.P. Mattila, K. Sabatini, and P.K. Kinnunen Interaction of cytochrome c with 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine: evidence for acyl chain reversal Langmuir 24 2008 4157 4160
58. M.E. Greenberg, X.M. Li, B.G. Gugiu, X. Gu, J. Qin, R.G. Salomon, and S.L. Hazen The lipid whisker model of the structure of oxidized cell membranes J. Biol. Chem. 283 2008 2385 2396
59. H. Khandelia, and O.G. Mouritsen Lipid gymnastics: evidence of complete acyl chain reversal in oxidized phospholipids from molecular simulations Biophys. J. 96 2009 2734 2743
60. S. Jayaraman, D.L. Gantz, and O. Gursky Effects of protein oxidation on the structure and stability of model discoidal high-density lipoproteins Biochemistry 47 2008 3875 3882
61. R.L. Artola, C.B. Conde, L. Bagatolli, R.P. Pecora, G.D. Fidelio, and S.C. Kivatinitz High-density lipoprotein from hypercholesterolemic animals has peroxidized lipids and oligomeric apolipoprotein A-I: its putative role in atherogenesis Biochem. Biophys. Res. Commun. 239 1997 570 574
62. J. Greilberger, and G. Jurgens Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1 Biochem. J. 331 1998 185 191
63. S. Canaan, R. Nielsen, F. Ghomashchi, B.H. Robinson, and M.H. Gelb Unusual mode of binding of human group IIA secreted phospholipase A2 to anionic interfaces as studied by continuous wave and time domain electron paramagnetic resonance spectroscopy J. Biol. Chem. 277 2002 30984 30990
64. G. Daniil, A.A. Phedonos, A.G. Holleboom, M.M. Motazacker, L. Argyri, J.A. Kuivenhoven, and A. Chroni Characterization of antioxidant/anti- inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders Clin. Chim. Acta 412 2011 1213 1220
65. S. Deakin, X. Moren, and R.W. James HDL oxidation compromises its influence on paraoxonase-1 secretion and its capacity modulate enzyme activity Arterioscler. Thromb. Vasc. Biol. 27 2007 1146 1152